Evidence map›Paper›PMID 41373635›Full record

ReviewInternational journal of molecular sciences2025

Lidia Boldeanu, Mihail Virgil Boldeanu, Marius Bogdan Novac, Mohamed-Zakaria Assani, Lucrețiu Radu

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Clinical Analysis ofPathogens (Basel, Switzerland) · 2026
    Article
  3. Article
  4. International journal of molecular sciences · 2026
    Review
  5. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
  6. Review
  7. Article
  8. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lidia BoldeanuDepartment of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0002-4817-1365
Mihail Virgil BoldeanuDepartment of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0003-2481-6138
Marius Bogdan NovacDepartment of Anesthesiology and Intensive Care, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Mohamed-Zakaria AssaniDepartment of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0009-0009-3146-8769
Lucrețiu RaduDepartment of Hygiene, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Opportunistic InfectionsSerratia InfectionsSerratia marcescensAnimalsAnti-Bacterial AgentsBiofilmsBiotechnologyHumansVirulence FactorsAnti-Bacterial AgentsVirulence Factorsantibiotic resistancebiofilmbiotechnologynosocomial infectionsprodigiosinSerratia marcescensvirulence

Identifiers

PMID41373635
PMCPMC12691863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.